Anterior Cruciate Ligament (ACL) Treatment — Guide — Cost, Top Hospitals & Success Rates | MyMedicPlus

The anterior cruciate ligament (ACL) is one of the four major stabilising ligaments of the knee joint, running diagonally from the anterior intercondylar area of the tibial plateau to the posterior medial surface of the lateral femoral condyle. It is the primary restraint to anterior tibial translation and a secondary restraint to tibial rotation, playing an essential role in knee stability during pivoting, cutting, landing, and deceleration movements. ACL rupture is among the most common serious sports injuries, affecting approximately 200,000 individuals annually in the United States.

ACL tears typically occur via non-contact mechanisms — sudden deceleration combined with valgus collapse, internal tibial rotation, and knee hyperextension — most commonly seen in football, basketball, skiing, netball, and rugby. Female athletes are 2–8 times more likely to sustain ACL injuries than males, attributed to anatomical (narrower notch width, greater tibial slope), hormonal, and neuromuscular factors. The injury is recognised by a 'pop' sensation, immediate haemarthrosis (blood in the joint), and subsequent knee instability on pivoting.

Management of ACL rupture ranges from conservative physiotherapy-based rehabilitation to arthroscopic ACL reconstruction. The choice depends on patient age, activity level, the presence of associated injuries (meniscal tears, collateral ligament injuries), the degree of instability, and the patient's goals. ACL reconstruction is a well-established procedure with high success rates in returning athletes to pre-injury level of sport, typically performed arthroscopically using autograft (patient's own tissue) or allograft (donor tissue).

Complete ACL rupture causing symptomatic knee instability — episodes of giving way, inability to pivot or cut without the knee buckling — is the primary indication for ACL reconstruction. Patients who wish to return to pivoting sports (football, rugby, basketball, skiing) or whose occupational demands involve physical activity are strongest candidates for surgical reconstruction. Approximately 70–80% of complete ACL tears are associated with meniscal tears (medial or lateral), which may be repaired or resected at the same arthroscopic procedure.

Partial ACL tears (Grade 1 or 2) or complete tears in older, lower-demand patients who are willing to modify their activities may be managed non-operatively with structured rehabilitation. The Scandinavian Delayed ACL Reconstruction study (KANON trial) demonstrated that a significant proportion (30–40%) of patients managed with structured physiotherapy ('active rehabilitation with optional delayed reconstruction') did not ultimately require surgery, suggesting that ACL reconstruction can be safely delayed in selected patients while functional rehabilitation is trialled.

Ideal candidates for ACL reconstruction are physically active patients aged 15–45 with confirmed complete ACL rupture on MRI, who have persistent instability symptoms after at least 6 weeks of rehabilitation, and who have clear goals of returning to pivoting sport or physical work. Associated reparable meniscal tears or multi-ligament injuries may make earlier surgery preferable. Adolescents with open physes (growth plates) require specialist consideration regarding graft placement to avoid physeal injury.

Contraindications to early ACL reconstruction include significant post-injury swelling and full range of motion loss (operating on an acutely swollen knee increases stiffness risk), active infection, severe degenerative osteoarthritis of the knee (limiting functional expectations), and significant medical comorbidities precluding safe surgery. Non-operative management is appropriate for older, less active patients who are willing to modify their activities to avoid pivoting and who have no episodes of instability in daily life. The MOON and MARS consortia's research supports individualised shared decision-making rather than a one-size-fits-all approach.

ACL reconstruction is performed arthroscopically under general or spinal anaesthesia. The procedure involves harvesting a graft, preparing the femoral and tibial tunnels at the anatomical ACL footprint, and fixing the graft within the tunnels using various fixation devices (interference screws, suspensory fixation buttons). Three main graft types are used: bone-patellar tendon-bone (BPTB) autograft, which has high tensile strength and excellent fixation (gold standard in elite athletes despite a higher donor-site morbidity); hamstring tendon (semitendinosus/gracilis) autograft, the most commonly used option with good outcomes and lower donor-site morbidity; and quadriceps tendon autograft, an increasingly popular option with good outcomes.

Allograft reconstruction (using donor tissue) avoids donor-site morbidity and reduces operative time but carries higher re-rupture rates in young active patients — allografts are therefore preferred in older patients (over 40) with lower functional demands. Anatomical single-bundle reconstruction targets the main bundle of the native ACL. Double-bundle reconstruction, addressing both AM (anteromedial) and PL (posterolateral) bundles, aims to restore rotational stability more completely and is used by some specialist surgeons, though meta-analyses have not consistently shown superiority over single-bundle for most patients.

Selecting the most appropriate Anterior Cruciate Ligament Treatment — Guide approach requires a structured assessment of patient-specific factors. The treating specialist evaluates disease severity, prior treatment history, comorbidities, and patient preferences before recommending a specific protocol. Combination approaches are often more effective than monotherapy — integrating pharmacological, procedural, or rehabilitative elements to address multiple disease mechanisms simultaneously. Dose or intensity is titrated incrementally based on clinical response, tolerability, and objective outcome measures. In patients with refractory disease or inadequate response to first-line protocols, escalation to higher-intensity or specialist-delivered treatment options is indicated. Multidisciplinary team (MDT) review ensures that surgical, medical, and allied health perspectives are integrated into the final management plan, particularly for complex or high-risk cases where multiple treatment pathways are viable and the risk-benefit balance requires careful deliberation.

ACL reconstruction achieves return to pre-injury sport in 65–82% of patients overall, with higher rates (82–90%) in elite athletes. The procedure effectively restores knee stability, eliminating giving-way episodes in over 90% of patients. Successful ACL reconstruction reduces the risk of secondary meniscal and cartilage injuries caused by repeated instability episodes — a significant long-term benefit as these injuries accelerate knee osteoarthritis development.

A well-conducted rehabilitation programme is as important as surgical technique for achieving optimal outcomes. Patients achieving full quadriceps and hamstring strength symmetry (greater than 90% limb symmetry index) and passing objective return-to-sport criteria before return have substantially lower re-rupture rates. The MOON prospective cohort showed significant improvements in KOOS (Knee Injury and Osteoarthritis Outcome Score) at 2 and 5 years post-reconstruction. Return-to-sport is safe — and strongly recommended — at 9 months or later for most patients, with recent evidence suggesting those returning before 9 months have higher re-rupture rates.

Graft re-rupture is the most significant long-term complication, occurring in 5–15% of patients at 5 years, with higher rates in young patients (under 20), female athletes, and those who return to high-demand sport — particularly in the first 6–9 months. Contralateral ACL rupture occurs at comparable rates, highlighting the importance of bilateral neuromuscular training in rehabilitation.

Post-operative stiffness (arthrofibrosis) — loss of full extension or flexion — occurs in approximately 4–6% of cases and is strongly associated with delayed surgery in the acutely inflamed knee, making pre-operative achievement of full range of motion essential. Donor-site morbidity from hamstring harvest (anterior knee pain, hamstring weakness) or patellar tendon harvest (patellar tendonitis, kneeling pain) affects approximately 10–20% of patients to some degree. Infection (less than 1%), deep vein thrombosis, nerve injury (saphenous nerve numbness), and surgical fixation failure are additional risks. The long-term risk of knee osteoarthritis following ACL injury is approximately 50% at 10–15 years, regardless of whether reconstruction is performed.

ACL rehabilitation is a 9–12 month journey divided into clear phases: immediate post-operative phase (0–2 weeks) focusing on swelling reduction, full extension, and quadriceps activation; early rehabilitation (weeks 2–8) focusing on range of motion, strength, and proprioception; intermediate phase (months 2–6) with progressive strength, agility, and sport-specific training; late rehabilitation (months 6–9) with return-to-training criteria assessment; and return to competition (after 9 months, contingent on passing objective functional tests).

Objective return-to-sport criteria — including single-leg squat, limb symmetry index for quadriceps and hamstring strength, hop tests — should be achieved before athletic return to reduce re-rupture risk. Physiotherapy at 3–5 sessions per week in the early phase, transitioning to 2 sessions and home exercises, is the standard care pathway. Follow-up with the orthopaedic surgeon occurs at 6 weeks, 3 months, and 6 months post-surgery. Bracing during return to sport is used by some surgeons but not routinely recommended as standard care.

ACL reconstruction in the United States costs approximately $15,000–30,000 as an outpatient procedure including surgeon, anaesthesia, implants, and facility fees. The extended rehabilitation programme adds $2,000–8,000 over the recovery period. Most US insurance plans cover ACL reconstruction when medically indicated. In the UK, NHS-funded ACL reconstruction is available, though waiting times can be 6–18 months in some areas.

For patients considering surgery abroad, India offers ACL reconstruction at JCI-accredited sports medicine and orthopaedic hospitals for $1,500–4,000 — a saving of 80–90%. Thai and Malaysian sports medicine centres offer comparable procedures at $2,000–5,000. International patients can access expert arthroscopic knee surgeons with fellowships from leading US and UK centres at a fraction of Western costs. Physiotherapy (both pre-operative preparation and post-operative rehabilitation) is excellent quality and very affordable. Patients typically plan a 2–3 week stay for surgery and initial physiotherapy, then continue rehabilitation at home.

Non-operative management with structured neuromuscular rehabilitation is a valid alternative for patients with partial tears, low physical demands, or willingness to modify activity. The KANON trial demonstrated equivalent outcomes between early reconstruction and delayed (or no) surgery in patients who adhered to progressive rehabilitation protocols. A 'wait and see' approach with rehabilitation is increasingly advocated as first-line for patients who are not immediately committed to returning to high-demand sport.

Primary ACL repair — suturing the torn ligament ends directly rather than replacing with a graft — is being investigated as an alternative to reconstruction in selected patients with proximal tears with adequate tissue quality. Early results from the BEAR trial (Bridge-Enhanced ACL Repair) using a collagen scaffold are promising, though long-term data are pending. For patients with chronic ACL deficiency causing severe knee osteoarthritis, total knee replacement addresses the arthritic joint rather than attempting late ligament reconstruction.